Skip to content
Visit the website
Organization profile · Investor

Active Partners

Consumer venture and growth investor · Founder capital and growth support

A consumer-focused investment firm backing founder-led brands and technologies from early stage through growth, with healthier living and wellness among its published themes.

Focus
Consumer brands + technology
Stage
Early stage through growth
Early cheque
–
Growth cheque
– average
Stage, cheque size and founder fit checkedReviewed

Who they back

Overview

Active Partners is a London investment firm focused exclusively on the consumer economy. It invests at early stage and growth stage, looking for founder-led brands and technologies with a differentiated proposition, strong customer engagement and potential to grow across markets.

Healthier living and wellness sits alongside education, responsible consumption and experiences within its consumer-investment focus.

At a glance

Best suited to
Founder-led consumer businesses
Active looks for a distinct product edge, engaged customers, ambitious founders, values and rapid-growth potential.
Investment stages
Early stage and growth
The firm publishes separate criteria and cheque ranges for the two routes.
Health relevance
Healthier living and wellness theme
Active said the theme represented 38% of its 2024 deals, including ARTAH, Healf, Mojo, OurRitual, Coopah and P.Happi.
Current vehicle
Not publicly named
The last independently confirmed vehicle is the Active Partners III, which closed in 2020. That close does not show which vehicle or capital is available today.

Company claims

  • Support for consumer-brand growth

    Active Partners says it supports founders of consumer brands through growth and global expansion.

Founder pathways

Investment routes

Choose the route by company stage and capital need, then use the portfolio and team records to test fit before making contact.

  • Early-stage investment

    For early-stage businesses reshaping the consumer economy, including the platforms that power consumer brands.

    –
    Review the early-stage route
  • Growth investment

    For businesses with strong product-market fit, high customer engagement and the potential for rapid growth, including companies not yet at breakeven.

    Average –
    Review the growth route
  • Portfolio review

    Use the portfolio filters and company stories to see how Active's thesis appears across stages, sectors and past outcomes.

    Public
    Explore the portfolio
  • Early-stage lead

    Profumo leads the early-stage fund and names healthcare and education among his areas of interest.

    Professional contact route
    Meet the early-stage lead

What shapes a fit

Investment approach

The firm describes a consistent consumer lens across early-stage and growth investing.

  • Distinctive proposition

    An edge

    Active looks for brands with a clear point of view and a product that changes the consumer experience.

  • Demand signal

    Customer engagement

    Community, advocacy and repeat engagement are central to the firm's view of durable consumer brands.

  • Leadership

    Visionary founders

    Active emphasizes founder purpose, ambition and the drive to build a defining business.

  • Scale

    Growth and global ambition

    The firm seeks rapid-growth potential and offers support with market entry, organizational scaling and senior talent.

    Eligible geographies and a current fund allocation by market are not published.

Stage + geography

Where the capital fits

Public criteria answer stage and cheque size more clearly than geography or current vehicle capacity.

Early stage
–
Mission-driven brands, consumer technologies and enabling platforms.
Growth
Average –
Rapid-growth consumer businesses with product-market fit and high customer engagement.
Base
London
The firm asks companies to have global ambition but does not publish a complete list of eligible founder domiciles.
Current capital
Confirm directly
Ask which vehicle, remaining allocation and decision timetable apply to the live round.

Investment lead

Early-stage decision-maker

Active says Tom Profumo leads its early-stage fund and is particularly interested in healthcare and education.

Partner · early-stage fund lead

Tom Profumo

Partner and early-stage fund lead — Joined Active in 2018 after consumer investment and corporate-finance roles; the official profile identifies healthcare and education as particular interests.

Track record + open questions

Public investment record

The public record is strongest on thesis, cheque ranges, team and named portfolio companies; live vehicle economics require confirmation.

What is publicly established

  • Active publishes distinct early-stage and growth criteria with – and average – cheque ranges.

  • Its 2024 review records 16 new investments and says healthier living and wellness accounted for 38% of that year's deals.

  • British Patient Capital's 1 April 2020 release documented a commitment to Active Partners III, which closed at in 2020. That is fund history, not a record of capital available today.

  • Companies House lists Active Partners Investments LLP as an active entity incorporated in 2004.

What to confirm for a live raise

  • Ask which vehicle, how much available capital and what remaining allocation by stage would apply to your round; the 2020 Active Partners III close does not answer that.

  • Stage criteria, cheque ranges, team and contact routes were last read on 31 August 2026; re-confirm them before approaching.

  • A portfolio listing shows the relationship but not ownership percentage, current valuation or a standardized company outcome.

  • The public approach describes support in broad terms; founders should agree governance, board involvement, reporting and operating support in the transaction documents.

Independent record

Fund and operating context

Independent and regulatory sources confirm the operating entity and the firm's last publicly documented fund close.

Independent and regulatory records

These records verify identity and the 2020 vehicle; they do not establish current available capital.

  • British Patient Capital commits to Active Partners IIIView source

    British Patient Capital

    Institutional investor announcement

    1 Apr 2020

  • Companies House

    UK company record

    Record checked August 2026

Common founder questions

Frequently asked questions

Transparency

Transparency and sources

Researched by Longevity.io

Reviewed

Directory listings are for informational purposes only. Inclusion does not constitute endorsement. Verify credentials and qualifications independently.

Keep exploring

Your Longevity Blueprint

Build your starting plan.

A few short questions, about two minutes. The Blueprint recommends where to start and explains why.

Build my Blueprint